German Guidelines for Hereditary Angioedema
... demonstrated efficacy in the treatment of laryngeal attacks [5, 12], attacks of abdominal pain [14] and skin swelling [21] from HAE-C1-INH. A randomised, double-blind, placebocontrolled study investigating the efficacy of a vapour-heated C1-INH concentrate by the company Baxter/Immuno was published ...
... demonstrated efficacy in the treatment of laryngeal attacks [5, 12], attacks of abdominal pain [14] and skin swelling [21] from HAE-C1-INH. A randomised, double-blind, placebocontrolled study investigating the efficacy of a vapour-heated C1-INH concentrate by the company Baxter/Immuno was published ...
Dyshidrotic Eczema - Toronto Dermatology Centre
... corticosteroids should not be applied more than twice a day; frequent use does not improve efficacy and increase the risk of side effects [14]. Topical immunomodulators such as tacrolimus and pimecrolimus are not as fast or effective as ultrapotent topical corticosteroids in the treatment of this sk ...
... corticosteroids should not be applied more than twice a day; frequent use does not improve efficacy and increase the risk of side effects [14]. Topical immunomodulators such as tacrolimus and pimecrolimus are not as fast or effective as ultrapotent topical corticosteroids in the treatment of this sk ...
You are here: » » Therapy
... Readers can decide for themselves when the loss to follow-up is excessive by assuming, in positive trials, that all patients lost from the treatment group did badly, and all lost from the control group did well, and then recalculating the outcomes under these assumptions. If the conclusions of the t ...
... Readers can decide for themselves when the loss to follow-up is excessive by assuming, in positive trials, that all patients lost from the treatment group did badly, and all lost from the control group did well, and then recalculating the outcomes under these assumptions. If the conclusions of the t ...
daclizumab
... beta-1a with respect to relapse and lesion activity • No significant difference between treatments with respect to disability progression • Daclizumab has increased ADE vs interferon beta-1a, so the net clinical benefit should be carefully considered ...
... beta-1a with respect to relapse and lesion activity • No significant difference between treatments with respect to disability progression • Daclizumab has increased ADE vs interferon beta-1a, so the net clinical benefit should be carefully considered ...
Retrospective Evaluation of Patients Diagnosed with Osteogenesis
... years after stopping therapy, BMD decreased, fracture rate increased, and bone pain began in four patients. This is the reason why authors recommend continuing pamidronate therapy during the growth period. After discontinuing pamidronate therapy, growth retardation and increased markers of bone reso ...
... years after stopping therapy, BMD decreased, fracture rate increased, and bone pain began in four patients. This is the reason why authors recommend continuing pamidronate therapy during the growth period. After discontinuing pamidronate therapy, growth retardation and increased markers of bone reso ...
Management of Congestive Heart Failure: Review Questions
... 1. (C) The most useful diagnostic test for evaluating CHF is 2-D echocardiography with Doppler flow studies. Echocardiography with Doppler study in patients with CHF helps to determine if the primary abnormality is pericardial, myocardial, or valvular and measures left ventricular ejection fraction ...
... 1. (C) The most useful diagnostic test for evaluating CHF is 2-D echocardiography with Doppler flow studies. Echocardiography with Doppler study in patients with CHF helps to determine if the primary abnormality is pericardial, myocardial, or valvular and measures left ventricular ejection fraction ...
alcohol withdrawal - Surgical Critical Care. Net
... (p<0.01) and anxiety (p<0.05) as well as increased tachycardia (p<0.05). Withdrawal symptoms were significantly less in the diazepam group (p<0.05). In a meta-analysis comparing numerous studies, analysis failed to show statistically significant differences between different benzodiazepines. (17). I ...
... (p<0.01) and anxiety (p<0.05) as well as increased tachycardia (p<0.05). Withdrawal symptoms were significantly less in the diazepam group (p<0.05). In a meta-analysis comparing numerous studies, analysis failed to show statistically significant differences between different benzodiazepines. (17). I ...
Candidiasis (Thrush)
... How is candidiasis treated? Treatment for candidiasis can be divided into two groups: • Local or topical treatments are applied to where the infection is found. They come in various forms, such as cream (clotrimazole), suppositories (miconazole), lozenges or liquids for gargling (nystatin). • System ...
... How is candidiasis treated? Treatment for candidiasis can be divided into two groups: • Local or topical treatments are applied to where the infection is found. They come in various forms, such as cream (clotrimazole), suppositories (miconazole), lozenges or liquids for gargling (nystatin). • System ...
Francisco Pernas, MD Faculty Advisor: Shraddha Mukerji, MD Department of Otolaryngology
... Ideally should Imaging not indicated for uncomplicated patients. CT scan may be indicated if suppurative complications suspected, patient fails be obtained after several weeks of medical therapy ...
... Ideally should Imaging not indicated for uncomplicated patients. CT scan may be indicated if suppurative complications suspected, patient fails be obtained after several weeks of medical therapy ...
Cat-scratch disease osteomyelitis from a dog scratch
... technology is available in a larger number of clinical microbiology laboratories than the IFA test. It is less observer-dependent and less labour-intensive, and can be an effective alternative to the IFA test for the diagnosis of CSD. Increased awareness and a comprehensive medical history are neede ...
... technology is available in a larger number of clinical microbiology laboratories than the IFA test. It is less observer-dependent and less labour-intensive, and can be an effective alternative to the IFA test for the diagnosis of CSD. Increased awareness and a comprehensive medical history are neede ...
Jemsek
... Lyme disease (LD) is a complex and potentially persistent or chronic condition that may affect the human host in many ways. LD is classically described as involving musculoskeletal, neurological (both brain and peripheral nervous system), and cardiac systems, and, while this is largely true, it only ...
... Lyme disease (LD) is a complex and potentially persistent or chronic condition that may affect the human host in many ways. LD is classically described as involving musculoskeletal, neurological (both brain and peripheral nervous system), and cardiac systems, and, while this is largely true, it only ...
2006 AHA Secondary Prevention Guidelines Slide Set
... healthcare professionals of effective, stateof-the art science related to the causes, prevention, detection, or management of cardiovascular diseases and stroke. - represent the consensus of the leading experts in cardiovascular disease and ...
... healthcare professionals of effective, stateof-the art science related to the causes, prevention, detection, or management of cardiovascular diseases and stroke. - represent the consensus of the leading experts in cardiovascular disease and ...
document
... • In 1998, knew missed doses led to resistant virus. • Since 1998, studies have demonstrated that adherence leads to lower viral loads, decreased AIDS progression, and increased survival. • For example, clients followed for 7 months ...
... • In 1998, knew missed doses led to resistant virus. • Since 1998, studies have demonstrated that adherence leads to lower viral loads, decreased AIDS progression, and increased survival. • For example, clients followed for 7 months ...
Vertigo
... • Foreign bodies and cerumen in the external ear • Otitis media with effusion • Acute suppurative otitis media – These patients are at risk for hearing loss (Toxic Labyrinthitis) ...
... • Foreign bodies and cerumen in the external ear • Otitis media with effusion • Acute suppurative otitis media – These patients are at risk for hearing loss (Toxic Labyrinthitis) ...
Characteristics of Graves` Disease in Haemodialysis Patients
... are referred to as the euthyroid sick syndrome associated with increased severity of non-thyroidal illness and mortality in cats and dogs. Hyperthyroidism is a very unusual condition in patients undergoing regular haemodialysis. Graves’ disease is rare in these patients. To our knowledge, till now o ...
... are referred to as the euthyroid sick syndrome associated with increased severity of non-thyroidal illness and mortality in cats and dogs. Hyperthyroidism is a very unusual condition in patients undergoing regular haemodialysis. Graves’ disease is rare in these patients. To our knowledge, till now o ...
UV-A1 Therapy for Nephrogenic Systemic Fibrosis
... were receiving hemodialysis before, during, and after presentation with NSF. Cutaneous improvement did not occur until after institution of UV-A1 therapy. After UV-A1 therapy was discontinued, no patient had a relapse, nor did any patient have spontaneous continued improvement (patients were in remi ...
... were receiving hemodialysis before, during, and after presentation with NSF. Cutaneous improvement did not occur until after institution of UV-A1 therapy. After UV-A1 therapy was discontinued, no patient had a relapse, nor did any patient have spontaneous continued improvement (patients were in remi ...
Fast Facts
... participation, and for 4 months after completion of study. Should a woman become pregnant or suspect while she or her partner is participating in this study, she should inform her treating physician immediately. 4. Patients must have histologically documented solid tumors or histologically confirmed ...
... participation, and for 4 months after completion of study. Should a woman become pregnant or suspect while she or her partner is participating in this study, she should inform her treating physician immediately. 4. Patients must have histologically documented solid tumors or histologically confirmed ...
A booklet about Multiple Sclerosis for family members
... unwilling to make the diagnosis of MS until there is good evidence for multiple lesions. While this may lead to long periods of uncertainty for both patient and physician about what the symptoms mean, most people will agree that it is best to be sure of the diagnosis before making it. WHAT HAPPENS ...
... unwilling to make the diagnosis of MS until there is good evidence for multiple lesions. While this may lead to long periods of uncertainty for both patient and physician about what the symptoms mean, most people will agree that it is best to be sure of the diagnosis before making it. WHAT HAPPENS ...
Paroxysmal atrial fibrillation associated with an attack of multiple
... & Oliphant, 1964). In a clinical study done by Yamour et al. (1980) on patients with cerebral haemorrhage, paroxysmal atrial fibrillation was associated specifically with bleeding in the brain-stem area. The patient we have reported presented with a neurological disease associated with paroxysmal at ...
... & Oliphant, 1964). In a clinical study done by Yamour et al. (1980) on patients with cerebral haemorrhage, paroxysmal atrial fibrillation was associated specifically with bleeding in the brain-stem area. The patient we have reported presented with a neurological disease associated with paroxysmal at ...
Paraneoplastic Cerebellar Degeneration
... Paraneoplastic cerebellum degeneration falls under a group of disorders called Paraneoplastic syndromes; they are usually degenerative and are triggered by the patient’s immune system in association with a malignant disease (Santacrose). These conditions are not due to the direct impact of the tumor ...
... Paraneoplastic cerebellum degeneration falls under a group of disorders called Paraneoplastic syndromes; they are usually degenerative and are triggered by the patient’s immune system in association with a malignant disease (Santacrose). These conditions are not due to the direct impact of the tumor ...
Protocol - Doncaster LMC
... secondary to primary care. GPs, as independent contractors, have the right to decline to take clinical and prescribing responsibilities for a patient on their medical list who is being treated elsewhere. However the reason for this action must be documented. In the view of the Doncaster & Bassetlaw ...
... secondary to primary care. GPs, as independent contractors, have the right to decline to take clinical and prescribing responsibilities for a patient on their medical list who is being treated elsewhere. However the reason for this action must be documented. In the view of the Doncaster & Bassetlaw ...
Treating CIDPhot!
... intravenous immunoglogulin (intravenous drip of blood product Intragam). Other treatments that have been suggested as working include chemotherapy, interferons, cyclosporin. The above three treatments are probably equivalent in their effectiveness in initial treatment of CIDP. They all have side-eff ...
... intravenous immunoglogulin (intravenous drip of blood product Intragam). Other treatments that have been suggested as working include chemotherapy, interferons, cyclosporin. The above three treatments are probably equivalent in their effectiveness in initial treatment of CIDP. They all have side-eff ...
Symptoms with late stage dementia residents display
... Negative behaviors include unsafe wandering, combative behavior, agitation, and loss of attentiveness (Reisberg, 1984). These symptoms tend to be exacerbated as their ability to navigate the environment decreases (Schaber, 2011) People in the late-stages of dementia present further challenges when i ...
... Negative behaviors include unsafe wandering, combative behavior, agitation, and loss of attentiveness (Reisberg, 1984). These symptoms tend to be exacerbated as their ability to navigate the environment decreases (Schaber, 2011) People in the late-stages of dementia present further challenges when i ...
Management of multiple sclerosis
Several therapies for multiple sclerosis (MS) exist, although there is no known cure. Multiple sclerosis is a chronic inflammatory demyelinating disease that affects the central nervous system (CNS).The most common initial course of the disease is the relapsing-remitting subtype, which is characterized by unpredictable attacks (relapses) followed by periods of relative remission with no new signs of disease activity. After some years, many of the people who have this subtype begin to experience neurologic decline without acute relapses. When this happens it is called secondary progressive multiple sclerosis. Other, less common, courses of the disease are the primary progressive (decline from the beginning without attacks) and the progressive-relapsing (steady neurologic decline and superimposed attacks). Different therapies are used for patients experiencing acute attacks, for patients who have the relapsing-remitting subtype, for patients who have the progressive subtypes, for patients without a diagnosis of MS who have a demyelinating event, and for managing the various consequences of MS.The primary aims of therapy are returning function after an attack, preventing new attacks, and preventing disability. As with any medical treatment, medications used in the management of MS may have several adverse effects, and many possible therapies are still under investigation. At the same time different alternative treatments are pursued by many patients, despite the paucity of supporting, comparable, replicated scientific study.This article focuses on therapies for standard MS; borderline forms of MS have particular treatments that are excluded.